Entrada Therapeutics TRDA
NASDAQ TRDA
$5.38 -0.30 (-5.28%)
At close: Oct 2, 2026 · 4:00 PM EDT

Entrada Therapeutics (TRDA) Change in Accured Expenses (2020 - 2026)

Updated

Entrada Therapeutics (TRDA) reported Change in Accured Expenses of $1.27 million for Q2 2026, down 70.5% from $4.31 million a year earlier.

Analysis

Entrada Therapeutics (TRDA) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Entrada Therapeutics' Change in Accured Expenses came in at $1.21 million, down 17.8% year-over-year; for FY2025, it was $4.74 million, up 177.6% from FY2024.

  • Change in Accured Expenses has a five-year compound annual growth rate of 52.3% (FY2020 to FY2025).
  • By year, Change in Accured Expenses came in at $1.71 million in FY2024 (-55.2%), $3.81 million in FY2023 (+116.3%), $1.76 million in FY2022 (-55.5%) and $3.96 million in FY2021 (+585.5%).
  • Five-year quarterly Change in Accured Expenses spans a low of -$5.95 million in Q1 2026 and a high of $6.9 million in Q3 2022.
  • Year over year, Change in Accured Expenses gained in three of the last four quarters, with growth averaging 32.0%.
  • The high point for year-over-year Change in Accured Expenses in five years was Q4 2021 (growth of 410.9%); the low point was Q2 2026 (a decline of 70.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$5.95 million (Q1 2026), $2.15 million (Q4 2025) and $3.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 2.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 1.20 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 338.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Entrada Therapeutics 221.16 Mn 221.16 Mn - 1.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.27 Mn
Mar 31, 2026 -5.95 Mn
Dec 31, 2025 2.15 Mn
Sep 30, 2025 3.74 Mn
Jun 30, 2025 4.31 Mn
Mar 31, 2025 -5.46 Mn
Dec 31, 2024 -425,000.00
Sep 30, 2024 3.04 Mn
Jun 30, 2024 1.62 Mn
Mar 31, 2024 -2.52 Mn
Dec 31, 2023 1.96 Mn
Sep 30, 2023 2.80 Mn
Jun 30, 2023 -5.05 Mn
Mar 31, 2023 4.11 Mn
Dec 31, 2022 -4.34 Mn
Sep 30, 2022 6.90 Mn
Jun 30, 2022 726,000.00
Mar 31, 2022 -1.53 Mn
Dec 31, 2021 1.82 Mn
Sep 30, 2021 2.07 Mn
API Access

Entrada Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=TRDA&period=max&api_key=YOUR_API_KEY